IKERCHEM

IKERCHEM is a Spanish biotechnology company focused on the discovery and development of innovative small molecule drugs for the treatment of cancer and other high-unmet-need diseases. Founded as a spin-off from the University of the Basque Country, the company leverages its expertise in organic chemistry and molecular modeling to design targeted therapies. Its research programs primarily target oncology, central nervous system disorders, and metabolic conditions. IKERCHEM operates through a collaborative model, working with academic institutions and pharmaceutical partners to advance its pipeline from early discovery through preclinical development.